Product news

Share this article:
The FDA has approved Novo Nordisk's PrandiMet, a combination of the insulin secretagogue repaglinide and metformin for the treatment of type 2 diabetes. 
 
Pasteur, the vaccines division of the Sanofi-Aventis Group, announced that the FDA has licensed Pentacel, a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in infants and children 6 weeks through 4 years of age (prior to age 5). 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.